Skip to content
2000
Volume 18, Issue 9
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Background: Sanguinarine, a benzophenanthridine alkaloid extracted from Sanguinaria canadensis has been found to show an inhibitory role on proapoptotic and growth inhibitory activities in various tumor cells of experimental subjects. Objective: This review highlights and summarizes the effects of sanguinarine against cancers alongside the possible mechanisms involved as depicted in various in vitro and in vivo models. Results: Sanguinarine shows anticancer activities via various mechanisms like inhibiting cancer cell proliferation, aberrantly activated signal transduction pathways, sang-mediated angiogenesis, and induction of cell death and tumor suppressors’ expressions. It also enhances the cytotoxic effects of chemotherapeutics via sensitizing cancer cells against these drugs, hence improving their pharmacological attributes. Conclusion: Due to the significant role of sanguinarine against various types of cancer, it can be explored for its potential functions in cancer treatment.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/1573407218666220119095852
2022-11-01
2025-06-18
Loading full text...

Full text loading...

/content/journals/cbc/10.2174/1573407218666220119095852
Loading

  • Article Type:
    Review Article
Keyword(s): anticancer agent; cytotoxic; human cancer; phytochemical; Sanguinarine; tumor cells
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test